-
Track & Monitor
Innovation in Pharmaceuticals: Anti-bacterial compositions
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the Pharmaceuticals industry’s Anti-bacterial compositions segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based on...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – malaria [strain NF-54] vaccine
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry malaria [strain NF-54] vaccine Drug Details Malaria vaccine (PfSPZ-GA1) is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – malaria [strain 7G8] vaccine
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry malaria [strain 7G8] vaccine Drug Details Vaccine candidate is under development for the prevention...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – malaria [strain NF-54] vaccine 2
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry malaria [strain NF-54] vaccine 2 Drug Details Vaccine candidate (PfSPZ vaccine) is under development...
-
Product Insights
Malaria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Malaria is a life-threatening blood disease caused by a parasite (Plasmodium) that is transmitted to humans by the Anopheles mosquito. People at increased risk of serious disease include young children and infants, travelers coming from areas with no malaria, and pregnant women and their unborn children. The Malaria pipeline market research report provides comprehensive information on the therapeutics under development for Malaria, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and...
-
Product Insights
Parasitic Diseases Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Parasitic Diseases Global Clinical Trials Review, H1, 2018" provides an overview of Parasitic Diseases clinical trials scenario. This report provides top line data relating to the clinical trials on Parasitic Diseases. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Malaria: Opportunity Analysis and Forecasts to 2027
Malaria is a potentially life-threatening disease caused by Plasmodium parasites, which are transmitted to humans through the bites of infected female Anopheles spp mosquitoes. For over 2,500 years, fevers, a hallmark symptom of malaria, were attributed to miasmas (foul stenches or vapors) rising from nearby swamps. Scientific studies of malaria became possible only after Charles Louis Alphonse Laveran’s discovery of the causative parasite in 1880 and the subsequent incrimination of mosquitoes as the vectors—first for avian malaria by Ronald Ross...